Sleep clinic statistics span several different measures: self-reported sleep symptoms, diagnosed disorders, referral pathways, diagnostic testing, treatment adherence and healthcare spending. The figures below identify the population, geography and measurement period for each measure so that survey estimates, claims cohorts, device data and coverage definitions are not treated as interchangeable.
Key Sleep Clinic Statistics
The most useful headline figures include:
- In 2017, 49.5% of adults in eight U.S. states and the District of Columbia reported trouble falling or staying asleep after age adjustment.
- In 2017, 23.1% of adults in the same eight-state and District of Columbia study reported unintentionally falling asleep.
- In 2020, 14.5% of U.S. adults had trouble falling asleep most days or every day during the prior 30 days.
- In 2024, 12.9% of U.S. adults used any sleep aid most days or every day during the prior 30 days.
- In 2018, 5.6% of the U.S. adult study population had a diagnosed sleep disorder, representing approximately 13.6 million adults.
- In 2018, adults with diagnosed sleep disorders averaged 16.3 office visits compared with 8.7 among adults without a sleep-disorder diagnosis.
- In 2018, incremental healthcare expense associated with diagnosed sleep disorders was $6,975 per adult in the United States.
- In a commercially insured U.S. OSA cohort, home sleep apnea testing was the first test for 30.8% of patients in the study’s five-pathway analysis.
- In the same OSA analysis, polysomnography followed by titration represented 19.8% of qualifying pathways.
- CMS defines a covered apnea event as cessation of airflow for at least 10 seconds under its Medicare sleep-study policy.
- CMS describes Type III home monitors as having at least four monitored channels.
- CMS says narcolepsy can ordinarily be confirmed by three sleep naps, with nap opportunities described at 20-minute intervals every two hours.
- In a 213,341-person commercially insured OSA cohort, 48% were objectively PAP-adherent during the first year after initiation.
- In a connected-device study of U.S. PAP users, 74.0% met CMS adherence criteria during the first 90 days.
- In an academic behavioral sleep medicine clinic, sleep medicine supplied 74.2% of referrals from 2014 through 2019.
- In 2024, women reported sleep-aid use at 14.8% versus 10.8% among men in the U.S. adult population.
Contents
- Sleep clinic referral and diagnostic testing statistics
- Sleep symptoms and patient-group data
- Sleep apnea and narcolepsy testing definitions
- Sleep disorder demand, utilization and cost statistics
- PAP treatment adherence and outcome statistics
- Sleep clinic access and referral utilization
Sleep Clinic Referral and Diagnostic Testing Statistics
A published analysis examined claims episodes for 86,827 commercially insured U.S. adults with obstructive sleep apnea (OSA). It found that 92.1% followed one of five qualifying diagnosis-to-treatment pathways, but the cohort represents commercially insured adults and is not a census of every patient or clinic. The OSA patient journey: pathways for diagnosis and treatment among commercially insured individuals in the United States
| Qualifying pathway or first test | Share of cohort | Measurement context |
|---|---|---|
| Home sleep apnea testing as first test | 30.8% | Commercially insured U.S. adults with OSA |
| Polysomnography without listed titration sequence | 23.6% | Study-specific claims pathway |
| Polysomnography followed by titration | 19.8% | Study-specific claims pathway |
| Split-night testing | 14.8% | Study-specific claims pathway |
| Home testing followed by titration | 3.2% | Pathways retained at a minimum 3% share |
These percentages describe claims-defined pathways, not clinical appropriateness or national utilization. The five reported shares sum to the study’s qualifying pathway group, while the study’s commercial-insurance design limits generalization to uninsured patients, other payers and clinics outside the claims population.
Sleep Clinic Statistics on Symptoms and Patient Groups
Symptoms help explain why people may seek evaluation, but survey responses do not establish a sleep-study diagnosis or clinic attendance. In the 2017 Behavioral Risk Factor Surveillance System study covering eight U.S. states and the District of Columbia, 49.5% of adults reported trouble falling or staying asleep after age adjustment, and 23.1% reported unintentionally falling asleep. Sleep Disorder Symptoms Among Adults in 8 States and the District of Columbia, 2017
Reported trouble falling or staying asleep varied by demographic group:
- Men reported the symptom at 43.8%, compared with 55.3% among women.
- The corresponding percentages were 52.0% for adults aged 18–44, 50.4% for those aged 45–64 and 41.6% for those aged 65 or older.
- The symptom was reported by 51.2% of non-Hispanic White adults, 44.6% of non-Hispanic Black adults and 41.9% of Hispanic adults.
Unintentional falling asleep showed a different pattern:
- The age-adjusted percentages were 21.2% among adults aged 18–44, 21.3% among adults aged 45–64 and 33.4% among adults aged 65 or older.
- The symptom was reported by 21.1% of non-Hispanic White adults, 32.8% of non-Hispanic Black adults and 23.8% of Hispanic adults.
National 2020 National Health Interview Survey data provide a separate measure. In the prior 30 days, 14.5% of U.S. adults had trouble falling asleep most days or every day, while trouble staying asleep was reported by 21.0% of non-Hispanic White adults, 15.4% of non-Hispanic Black adults, 10.6% of Hispanic adults and 8.7% of non-Hispanic Asian adults. Sleep Difficulties in Adults: United States, 2020
The 2024 National Center for Health Statistics measure concerns sleep-aid use rather than symptoms or clinic visits. Any sleep-aid use most days or every day in the prior 30 days was reported by 12.9% of U.S. civilian, noninstitutionalized adults aged 18 or older; the percentage was 14.8% among women and 10.8% among men. Use of Sleep Aids Among Adults Age 18 and Older: United States, 2024
Sleep Clinic Testing Statistics for Sleep Apnea and Narcolepsy
Medicare coverage terminology supplies operational definitions that are useful for interpreting sleep-clinic testing, but these are policy thresholds rather than population prevalence statistics. CMS generally says Medicare beneficiaries pay 20% of the Medicare-approved amount after the Part B deductible for covered sleep studies; actual costs depend on the deductible, facility, assignment and other insurance. LCD – Polysomnography and Other Sleep Studies (L36902)
Under the CMS LCD:
- Apnea is defined as cessation of airflow for at least 10 seconds.
- A covered hypopnea uses at least a 30% reduction in thoracoabdominal movement or airflow plus at least 4% oxygen desaturation.
- Type III monitors have a minimum of four monitored channels.
- The positive OSA criterion includes an AHI or RDI of at least 15 events per hour, with a minimum of 30 events.
- An alternative route uses an AHI or RDI of 5–14 events per hour, at least 10 events, plus qualifying symptoms or conditions.
For narcolepsy, CMS says the condition can ordinarily be confirmed by three sleep naps. Its description of the multiple sleep latency test gives nap opportunities lasting 20 minutes at two-hour intervals, although coverage language and clinical testing practice should not be read as a measured national clinic-throughput statistic.
Sleep Disorder Demand, Utilization and Cost Statistics
A 2018 Medical Expenditure Panel Survey analysis estimated that 5.6% of the U.S. study population had a diagnosed sleep disorder, or approximately 13.6 million adults. This was a conservative diagnosed prevalence estimate based on MEPS ICD-10 G47.x conditions, so it does not represent every person with symptoms or an undiagnosed disorder. Incremental health care utilization and expenditures for sleep disorders in the United States
| 2018 MEPS measure | Adults with diagnosed sleep disorder | Adults without diagnosis |
|---|---|---|
| Office visits per person | 16.3 | 8.7 |
| Emergency-room visits per person | 0.52 | 0.37 |
| Prescriptions per person | 39.7 | 21.9 |
The study estimated incremental total healthcare expense associated with diagnosed sleep disorders at $6,975 per adult and approximately $94.9 billion nationally in 2018. These are adjusted and model-based healthcare estimates, not the amount charged by a sleep clinic or the cost of an individual sleep study.
A separate Cerner Health Facts analysis covered approximately 68.7 million patients and 506.9 million encounters across 100 nonaffiliated healthcare systems from 2000 through 2017. It identified approximately 20.5 million patients with sleep disorders and 127.4 million outpatient encounters, but the database is not a nationally representative clinic census. Outpatient health care utilization for sleep disorders in the Cerner Health Facts database
Among pediatric encounters in that database, sleep-related breathing disorders ranked at 820.1 per 100,000 encounters, followed by insomnia at 181.6, sleep movement disorders at 68.3, hypersomnolence at 48.1 and circadian-rhythm disorders at 16.2 per 100,000 encounters. These are encounter rates among children aged 0–18, not prevalence rates in the child population.
Sleep Clinic Treatment and PAP Adherence Outcomes
Positive airway pressure (PAP) adherence varies with the measurement method. In a commercially insured U.S. cohort of 213,341 adults aged 18–64 with OSA, 48% were objectively device-adherent during the first year after PAP initiation.
Claims algorithms classified between 10% and 84% as adherent, while their accuracy against objective device usage ranged from 53% to 68% and specificity from 26% to 92%. Performance of Claims-Based Algorithms for Adherence to Positive Airway Pressure Therapy in Commercially Insured Patients With OSA
The same linked claims-and-device study reported these first-year usage comparisons:
- Objectively device-adherent patients averaged 339.9 days of PAP use, compared with 260.0–290.0 days among claims-adherent groups.
- Objectively device-adherent patients averaged 6.6 nights per week, compared with 5.1–5.6 nights in claims-adherent groups.
- Objectively device-adherent patients averaged 6.4 hours per day, compared with 4.6–5.2 hours in claims-adherent groups.
A much larger connected-device study included 4,181,490 PAP users and applied the CMS adherence definition of at least four hours per night on at least 70% of nights during the first 90 days. The observed rates were 74.0% in the United States, 71.7% in Brazil and 66.4% in Mexico. Adherence with positive airway pressure therapy for obstructive sleep apnea in developing vs. developed countries: a big data study
These country figures describe ResMed AirView-connected users, not all PAP users in each country. The commercial-insurance cohort, connected-device cohort and claims definitions therefore answer different questions about treatment use.
Sleep Clinic Access and Referral Utilization
Referral data show how one academic behavioral sleep medicine service received patients, rather than how all sleep clinics are accessed. In an urban Midwestern U.S. academic health system, sleep medicine supplied 74.2% of behavioral sleep medicine referrals from 2014 through 2019, while neurology and psychiatry together supplied 7.3%. Patient accessibility and utilization of behavioral sleep medicine referrals in an academic center
The single-center retrospective design matters when interpreting these percentages: referral mix can reflect local staffing, specialty relationships, insurance arrangements and the clinic’s service model. It should not be treated as a national distribution of referral sources.
The American Academy of Sleep Medicine’s patient-volume reporting materials describe clinic, in-lab, home sleep apnea testing and equipment statistics with a six-month reporting window. Those figures are accreditation or reporting definitions, not measured national utilization rates. Patient Volume and Statistics Form Fact Sheet
Taken together, the available evidence separates several stages of the sleep-care pathway: symptoms reported in population surveys, recognized diagnoses in administrative data, testing pathways in insured claims, referrals within a single academic service and PAP adherence among linked device users. Each stage has a different denominator, period and limitation, so a sleep clinic statistic is most informative when its population and measurement method are stated alongside the number.